Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$3.07 USD
+0.01 (0.33%)
Updated May 2, 2024 04:00 PM ET
After-Market: $3.06 -0.01 (-0.33%) 6:44 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/3/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | -29.41% |
ABR | 1.22 |
Earnings ESP
|
5.11% |
---|---|
Current Year | -0.73 |
Next Year | -0.38 |
EPS (TTM) | -0.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.11M | 0.12M | 4.45M | 20.37M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 0.17M | 0.19M | 16.30M | 33.06M |
Low Estimate | 0.05M | 0.08M | 0.28M | 0.87M |
Year ago Sales | 0.07M | 0.08M | 0.39M | 4.45M |
Year over Year Growth Est. | 50.00% | 46.25% | 1,035.23% | 357.64% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.23 | -0.73 | -0.38 |
# of Estimates | 6 | 5 | 7 | 6 |
Most Recent Consensus | -0.22 | -0.24 | -0.75 | -0.62 |
High Estimate | -0.17 | -0.18 | -0.04 | 1.01 |
Low Estimate | -0.27 | -0.28 | -1.07 | -0.86 |
Year ago EPS | -0.19 | -0.18 | -0.74 | -0.73 |
Year over Year Growth Est. | -21.05% | -27.78% | 1.35% | 47.55% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 4 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.23 | -0.73 | -0.38 |
7 Days Ago | -0.22 | -0.21 | -0.65 | -0.20 |
30 Days Ago | -0.24 | -0.22 | -0.64 | -0.10 |
60 Days Ago | -0.18 | -0.17 | -0.43 | -0.60 |
90 Days Ago | -0.18 | -0.17 | -0.43 | -0.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.23 | -0.85 | -0.66 |
Zacks Consensus Estimate | -0.23 | -0.23 | -0.73 | -0.38 |
Earnings ESP | 5.11% | -2.34% | -16.90% | -72.81% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.16 | -0.18 | -0.19 | NA |
Estimate | -0.17 | -0.18 | -0.21 | -0.18 | NA |
Difference | -0.05 | 0.02 | 0.03 | -0.01 | 0.00 |
Surprise | -29.41% | 11.11% | 14.29% | -5.56% | -2.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more